Hemostemix Inc Cash Flow-to-Debt Ratio
Hemostemix Inc cash flow-to-debt ratio. Hemostemix Inc (HEM) has a Cash Flow-to-Debt Ratio of -0.61x as of September 2025, meaning its operating cash flow of CA$-2.91 Million could theoretically repay -1% of its total liabilities (CA$4.80 Million) in one year. See Hemostemix Inc (HEM) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hemostemix Inc (2013–2024)
Cash flow-to-debt ratio of Hemostemix Inc from 2013 to 2024. Historical debt coverage capacity for Hemostemix Inc across 12 annual periods. Check Hemostemix Inc (HEM) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Hemostemix Inc Cash Flow-to-Debt Ratio by Year (2013–2024)
Hemostemix Inc cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for Hemostemix Inc. For the full cash flow conversion analysis, see Hemostemix Inc (HEM) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.23x | CA$-1.90 Million | CA$8.20 Million | ▼ -19.1% |
| 2023 | -0.19x | CA$-1.50 Million | CA$7.68 Million | ▲ +76.9% |
| 2022 | -0.84x | CA$-6.10 Million | CA$7.23 Million | ▼ -41.8% |
| 2021 | -0.59x | CA$-3.48 Million | CA$5.85 Million | ▲ +65.9% |
| 2020 | -1.75x | CA$-5.98 Million | CA$3.42 Million | ▼ -112.9% |
| 2019 | -0.82x | CA$-3.40 Million | CA$4.15 Million | ▲ +64.2% |
| 2018 | -2.29x | CA$-2.69 Million | CA$1.17 Million | ▲ +66.9% |
| 2017 | -6.91x | CA$-3.21 Million | CA$464.79K | ▼ -848.1% |
| 2016 | -0.73x | CA$-2.69 Million | CA$3.69 Million | ▲ +87.2% |
| 2015 | -5.69x | CA$-3.55 Million | CA$622.73K | ▼ -0.2% |
| 2014 | -5.68x | CA$-3.13 Million | CA$551.70K | ▼ -24.7% |
| 2013 | -4.56x | CA$-1.11 Million | CA$242.98K | — |